MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA

Image for article MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
News Source : Financial Post

News Summary

  • MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) today announced its financial results for the three months ended March 31, 2026 (“Q1 2026”) The company achieved positive adjusted EBITDA, reflecting disciplined execution and continued cost control aligned with the Company’s strategic roadmap to profitability.
  • The Company remains committed to serving patients and wellness consumers through its direct-to-patient medical platform, its established clinic network, Harvest Medicine, and its expanding wellness portfolio.
This press release contains references to Adjusted EBITDA which is a nonIFRS financial measure. Management believes that this supplementary nonIFRS financial measure provides useful additional info [+4935 chars]

Must read Articles